These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1489178)

  • 1. In vitro activity of RU 29246, the active compound of the cephalosporin prodrug ester HR 916.
    Riess G; Andrews J; Thornber D; Wise R
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2360-4. PubMed ID: 1489178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. I. Antibacterial activity in vitro.
    Bauernfeind A; Jungwirth R; Eberlein E; Klesel N; Adam F; Isert D; Limbert M; Markus A; Schrinner E; Seibert G
    J Antibiot (Tokyo); 1992 Apr; 45(4):505-20. PubMed ID: 1592683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity and beta-lactamase stability of the new oral cephalosporin Bay v 3522.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1990 Sep; 9(9):685-91. PubMed ID: 2226499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antimicrobial activity of RU-59863, a C-7 catechol substituted cephalosporin.
    Erwin ME; Varnam D; Jones RN
    Diagn Microbiol Infect Dis; 1997 Jun; 28(2):93-100. PubMed ID: 9239501
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro evaluation of HR810, a new wide-spectrum aminothiazolyl alpha-methoxyimino cephalosporin.
    Jones RN; Thornsberry C; Barry AL
    Antimicrob Agents Chemother; 1984 Jun; 25(6):710-8. PubMed ID: 6611135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro evaluation of Ro 09-1227, a novel catechol-substituted cephalosporin.
    Jones RN; Erwin ME
    Antimicrob Agents Chemother; 1992 Jan; 36(1):233-8. PubMed ID: 1590695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RU 29 246, the active compound of the cephalosporin-prodrug-ester HR 916. II. Stability to beta-lactamases and affinity for penicillin-binding proteins.
    Markus A; Klesel N; Wollmann T; Isert D; Limbert M; Schrinner E; Seibert G; Bauernfeind A; Jungwirth R; Wilhelm R
    J Antibiot (Tokyo); 1992 Apr; 45(4):521-6. PubMed ID: 1592684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro activity of a catechol-substituted cephalosporin, GR69153.
    Wise R; Andrews JM; Ashby JP; Thornber D
    Antimicrob Agents Chemother; 1991 Feb; 35(2):329-34. PubMed ID: 2024966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of E-1040, a novel thiadiazolyl cephalosporin compared with other parenteral cephems.
    Jones RN; Erwin ME; Barrett MS; Johnson DM; Briggs BM
    Diagn Microbiol Infect Dis; 1991; 14(4):301-9. PubMed ID: 1889181
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activity of ceftaroline (PPI-0903M, T-91825) against bacteria with defined resistance mechanisms and phenotypes.
    Mushtaq S; Warner M; Ge Y; Kaniga K; Livermore DM
    J Antimicrob Chemother; 2007 Aug; 60(2):300-11. PubMed ID: 17548456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activity and beta-lactamase stability of GR69153, a new long-acting cephalosporin.
    Chin NX; Gu JW; Fang W; Neu HC
    Antimicrob Agents Chemother; 1991 Feb; 35(2):259-66. PubMed ID: 2024959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative in vitro activity and beta-lactamase stability of RU29246, the active metabolite of HR916B.
    Yu KW; Chin NX; Neu HC
    Eur J Clin Microbiol Infect Dis; 1992 Jul; 11(7):652-9. PubMed ID: 1396779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cefquinome (HR 111V). In vitro evaluation of a broad-spectrum cephalosporin indicated for infections in animals.
    Murphy SP; Erwin ME; Jones RN
    Diagn Microbiol Infect Dis; 1994 Sep; 20(1):49-55. PubMed ID: 7867299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity evaluations of cefdinir (FK482, CI-983, and PD134393). A novel orally administered cephalosporin.
    Briggs BM; Jones RN; Erwin ME; Barrett MS; Johnson DM
    Diagn Microbiol Infect Dis; 1991; 14(5):425-34. PubMed ID: 1797457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BMY-28100, a new oral cephalosporin: antimicrobial activity against nearly 7,000 recent clinical isolates, comparative potency with other oral agents, and activity against beta-lactamase producing isolates.
    Jones RN; Barry AL
    Diagn Microbiol Infect Dis; 1988 Jan; 9(1):11-26. PubMed ID: 3259489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro activity of BAY v 3522, a new oral cephalosporin.
    Fass RJ
    Antimicrob Agents Chemother; 1990 Sep; 34(9):1855-7. PubMed ID: 2126697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vitro activity and beta-lactamase stability of FK482, a new oral cephalosporin.
    Neu HC; Saha G; Chin NX
    Antimicrob Agents Chemother; 1989 Oct; 33(10):1795-800. PubMed ID: 2589845
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of cefquinome, a new cephalosporin, compared with other cephalosporin antibiotics.
    Chin NX; Gu JW; Fang W; Neu HC
    Diagn Microbiol Infect Dis; 1992; 15(4):331-7. PubMed ID: 1611848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro evaluation of a novel ketolide antimicrobial agent, RU-64004.
    Jamjian C; Biedenbach DJ; Jones RN
    Antimicrob Agents Chemother; 1997 Feb; 41(2):454-9. PubMed ID: 9021207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro activity of cefcanel versus other oral cephalosporins.
    Chin NX; Gu JW; Neu HC
    Eur J Clin Microbiol Infect Dis; 1991 Aug; 10(8):676-82. PubMed ID: 1748125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.